Explorer›Bordetella pertussis›Open Science
Research PaperResearchia:202606.22005

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420

May ElSherif

Abstract

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420 --- Source: OpenAlex - medRxiv (Citations: 2) PDF: https://www.medrxiv.org/content/medrxiv/early/2026/06/15/2026.06.09.26355227.full.pdf Original Link: https://doi.org/https://doi.org/10.64898/2026.06.09.26355227

Submitted: June 22, 2026Subjects: Open Science; Bordetella pertussis

Description / Details

A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420

Source: OpenAlex - medRxiv (Citations: 2) PDF: https://www.medrxiv.org/content/medrxiv/early/2026/06/15/2026.06.09.26355227.full.pdf Original Link: https://doi.org/https://doi.org/10.64898/2026.06.09.26355227

Please sign in to join the discussion.

No comments yet. Be the first to share your thoughts!

Access Paper
View Source PDF
Submission Info
Date:
Jun 22, 2026
Topic:
Bordetella pertussis
Area:
Open Science
Comments:
0
Bookmark
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420 | Researchia